Medivir to present mature clinical data for fostrox + Lenvima at ESMO Conference and to host a webcast on September 16

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of

READ MORE